A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : 5-FU

Search Conditions:
Search Keyword : 5-FU
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: 5-FU
Appearance Frequency: 11194 time(s)
Long forms: 60

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
5-fluorouracil
(11097 times)
Neoplasms
(5637 times)
TS (550 times)
CRC (491 times)
LV (485 times)
1963 EVALUATION OF 5-FLUOROURACIL (5-FU) IN SURGICAL PRACTICE.
5-fluorouridine
(14 times)
Biochemistry
(5 times)
DAC (3 times)
GC (3 times)
NPs (2 times)
1977 The ribosomes of Drosophila. Normal and defective ribosome biosynthesis in Drosophila cell cultures.
cisplatin-5-fluorouracil
(5 times)
Neoplasms
(5 times)
SCCHN (2 times)
CI (1 time)
CR (1 time)
2002 Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients.
5-FU group
(4 times)
Ophthalmology
(3 times)
IOP (3 times)
MMC (2 times)
POAG (2 times)
1989 Effect of postoperative subconjunctival 5-fluorouracil injections on the surgical outcome of trabeculectomy in the Japanese.
5-fluoro-2,4-pyrimidinedione
(3 times)
Pharmacology
(2 times)
DA (2 times)
ACh (1 time)
CNS (1 time)
1980 Effects on 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione(FD-1) on the central nervous system: 1. Effects on monoamines in the brain.
5-fluoropyrimidine
(3 times)
Neoplasms
(3 times)
PFS (2 times)
ABCG2 (1 time)
cHCC-CCA (1 time)
2004 Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer.
5-fluorouracil 5% cream
(3 times)
Dermatology
(2 times)
AK (2 times)
ALA (1 time)
CENTRAL (1 time)
2015 A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis.
5-fluorouracil alone
(3 times)
Gastroenterology
(1 time)
i.v (2 times)
OXA (2 times)
OXFU (2 times)
2000 5-fluorouracil alone versus 5-fluorouracil plus folinic acid in the treatment of colorectal carcinoma: meta-analysis.
5-fluorouracil-based
(3 times)
Neoplasms
(3 times)
MSS (1 time)
1996 Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis.
10  non-5-fluorouracil
(3 times)
Neoplasms
(2 times)
AE (1 time)
BTB (1 time)
CR (1 time)
1985 Pluripotential hematopoietic stem cells in post-5-fluorouracil murine bone marrow express the Thy-1 antigen.
11  ((3)H)5-fluorouracil
(2 times)
Neoplasms
(1 time)
CP (1 time)
CT (1 time)
hNT1 (1 time)
1998 Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.
12  5-fluorouracil-induced
(2 times)
Antineoplastic Agents
(1 time)
5-FU-La (1 time)
i.p (1 time)
2015 Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice.
13  5-FU (civ)
(2 times)
Antineoplastic Agents
(2 times)
CDHP (2 times)
SRC (2 times)
2000 Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU from bench to clinic.
14  5-FU + cisplatin
(2 times)
Neoplasms
(1 time)
CT (1 time)
RT (1 time)
1987 Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
15  5-FU resistance
(2 times)
Gastroenterology
(1 time)
MRP1 (1 time)
P-gp (1 time)
PKC (1 time)
2016 Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo.
16  futraful, uracil and 5-fluorouracil
(2 times)
Antineoplastic Agents
(2 times)
BI (1 time)
BII (1 time)
FT (1 time)
1992 [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
17  (5-FU) and GEM metabolic factors
(1 time)
Gastroenterology
(1 time)
GEM (1 time)
TS (1 time)
2010 Contribution of thymidylate synthase to gemcitabine therapy for advanced pancreatic cancer.
18  (5-FU)-resistant Bel7402
(1 time)
Neoplasms
(1 time)
HCC (1 time)
OPN3 (1 time)
2012 Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
19  1-(2-tetrahydrofuryl)-5-fluorouracil
(1 time)
Neoplasms
(1 time)
BBN (1 time)
DNA (1 time)
RNA (1 time)
2008 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
20  3-acetyl-5-fluorouracil
(1 time)
Pharmacology
(1 time)
--- 1993 Structure of 3-acetyl-5-fluorouracil (5-FU): implication for its rearrangements during hydrolysis and upon heating.
21  5-(6-3H)-fluorouracil
(1 time)
Neoplasms
(1 time)
--- 2000 Correlation between tumour blood flow and fluorouracil distribution in a hypovascular liver metastasis model.
22  5-fluoro-2'-deoxyuridine
(1 time)
Neoplasms
(1 time)
EGFR (1 time)
2002 Biological basis for chemo-radiotherapy interactions.
23  5-fluorodeoxyuridine
(1 time)
Biochemistry
(1 time)
ODNs (1 time)
2010 Monitoring of duplex and triplex formation by 19F NMR using oligodeoxynucleotides possessing 5-fluorodeoxyuridine unit as 19F signal transmitter.
24  5-Fluorouracil 100mg/kg
(1 time)
General Surgery
(1 time)
PH (1 time)
SOS (1 time)
2015 Hepatic regeneration in a rat model is impaired by chemotherapy agents used in metastatic colorectal cancer.
25  5-fluorouracil 400 mg/m2 per day
(1 time)
Neoplasms
(1 time)
--- 1991 Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.
26  5-fluorouracil needling
(1 time)
Ophthalmology
(1 time)
MMC (1 time)
NPDS (1 time)
2011 Resources use, costs and effectiveness of non-penetrating deep sclerectomy according to glaucoma stage.
27  5-fluorouracil treatment
(1 time)
Genetics
(1 time)
SpD (1 time)
2015 A Diet Containing Beta-Hydroxy-Beta-Methylbutyrate, L-Glutamine and L-Arginine Ameliorates Chemoradiation-Induced Gastrointestinal Injury in Rats.
28  5-fluorouracil, consists of tegafur
(1 time)
Antineoplastic Agents
(1 time)
--- 2001 [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
29  5-fluorouracil-1-yl-aceto amino acid, 5-FUAA
(1 time)
Allergy and Immunology
(1 time)
5-FUAA-BSA (1 time)
5-FUAA-OVA (1 time)
BSA (1 time)
2016 [Preparation and characterization of polyclonal antibody against 5-fluorouracil].
30  5-fluorouracil-resistant
(1 time)
Neoplasms
(1 time)
CRC (1 time)
EMT (1 time)
2017 Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.
31  5-fluorouridine-containing
(1 time)
Biochemistry
(1 time)
MN (1 time)
Psi (1 time)
snRNA (1 time)
1997 Modification of human U4 RNA requires U6 RNA and multiple pseudouridine synthases.
32  5-fluoruracil/capecitabine
(1 time)
Neoplasms
(1 time)
AEs (1 time)
PA (1 time)
SCC (1 time)
2018 Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes.
33  5-fluourouracil-loaded polyactic acid nanoparticles PLA
(1 time)
Ophthalmology
(1 time)
--- 2006 [Experimental study on 5-fluourouracil-loaded immunonanoparticles targeting to lens epithelial cells].
34  5-FU arm
(1 time)
Antineoplastic Agents
(1 time)
NDP (1 time)
PS (1 time)
2007 [Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
35  5-FU by CVI
(1 time)
Antineoplastic Agents
(1 time)
CVI (1 time)
1999 [Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer].
36  5-FU from drug
(1 time)
Biology
(1 time)
beta-CD (1 time)
EE (1 time)
FTIR (1 time)
2016 Formation and characterization of beta-cyclodextrin (beta-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
37  5-FU persistent arterial method
(1 time)
Antineoplastic Agents
(1 time)
FAM (1 time)
IP (1 time)
1994 [A study of various complications in arterial infusion chemotherapy].
38  5-FU resistant cell line H630
(1 time)
Neoplasms
(1 time)
CRC (1 time)
DS (1 time)
2003 Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines.
39  5-FU, 600 mg/m2 intravenously weekly
(1 time)
Neoplasms
(1 time)
LDH (1 time)
1986 Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
40  5-FU-HAGS
(1 time)
Nanotechnology
(1 time)
PLGA (1 time)
2013 Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
41  5-FU-resistant cell line
(1 time)
Complementary Therapies
(1 time)
CCK-8 (1 time)
FCM (1 time)
HSP-27 (1 time)
2018 Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
42  5-FUci
(1 time)
Neoplasms
(1 time)
VEGF (1 time)
2007 Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
43  5-FUra
(1 time)
Antineoplastic Agents
(1 time)
HU (1 time)
1985 Factors modifying cytotoxicity induced by 5-FU and hydroxyurea.
44  5FU-AEs
(1 time)
Genetics, Medical
(1 time)
AEs (1 time)
2016 Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance).
45  docetaxel-5-fluorouracil
(1 time)
Neoplasms
(1 time)
ORR (1 time)
SCCHN (1 time)
2004 Docetaxel plus 5-fluorouracil in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter study.
46  drugs-5-fluorouracil
(1 time)
Environmental Health
(1 time)
CisPt (1 time)
ET (1 time)
hpf (1 time)
2016 Acute and sub-chronic toxicity of four cytostatic drugs in zebrafish.
47  Facilitated uptake of 5-fluorouracil
(1 time)
Nanotechnology
(1 time)
--- 2016 Transmembrane delivery of anticancer drugs through self-assembly of cyclic peptide nanotubes.
48  failure undergoing trabeculectomy with 5-Fluorouracil
(1 time)
Ophthalmology
(1 time)
IOP (1 time)
1993 Intra-operative use of 5-fluorouracil in glaucoma filtering surgery.
49  first-line chemotherapy combination with lrinotecan+5-Fluorouracil
(1 time)
Neoplasms
(1 time)
ACC (1 time)
OS (1 time)
PD (1 time)
2002 Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy.
50  first-line treatment was cisplatin+5-fluorouracil
(1 time)
Neoplasms
(1 time)
HCRU (1 time)
PS (1 time)
SCCHN (1 time)
2018 Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom.
51  Fluoro Uracil
(1 time)
Cell Biology
(1 time)
bFGF (1 time)
DPD (1 time)
TPP (1 time)
2009 Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1.
52  Fluoro-uracile, Roche, France
(1 time)
Antineoplastic Agents
(1 time)
HPLC (1 time)
1992 Modification of the physicochemical and pharmacological properties of anticancer platinum compounds by commercial 5-fluorouracil formulations: a comparative study using cisplatin and carboplatin.
53  Fluoroblastin, Farmitalia, Freiburg, Germany
(1 time)
Gastroenterology
(1 time)
CAI (2 times)
1997 Celiac artery adjuvant chemotherapy. Results of a prospective trial.
54  Fluoropyrimidines-5-fluorouracil
(1 time)
Neoplasms
(1 time)
--- 2016 Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.
55  fluorouracil-resistant SNU-C5
(1 time)
Pharmacology
(1 time)
--- 2016 The Effect of (1S,2S,3E,7E,11E)-3,7,11,15-Cembratetraen-17,2-Olide (LS-1) from Lobophyyum sp. on the Apoptosis Induction of SNU-C5 Human Colorectal Cancer Cells.
56  frequently used chemotherapeutic drug 5-fluorouracil
(1 time)
Cardiology
(1 time)
--- 2005 Coronary artery spasm induced by 5-fluorouracil.
57  frequently used drugs: 5-fluorouracil
(1 time)
Drug Therapy
(1 time)
FUdR (1 time)
1998 Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.
58  FU-ALA-PDT
(1 time)
Diagnostic Imaging
(1 time)
ALA-PDT (1 time)
2016 Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
59  FU-PLA-mc
(1 time)
General Surgery
(1 time)
--- 1986 [A new anticancer preparation, 5-fluorouracil-poly-L-lactic acid microcapsule, and its therapeutic evaluation].
60  gemcitabine-5-fluorouracil
(1 time)
Neoplasms
(1 time)
AIO (1 time)
2007 Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).